Biosyntech Pink Sheet Forecast - Naive Prediction

The Naive Prediction forecasted value of Biosyntech on the next trading day is expected to be 0.000003 with a mean absolute deviation of 0.000095 and the sum of the absolute errors of 0.01. Biosyntech Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Biosyntech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 25th of January 2026 the relative strength index (rsi) of Biosyntech's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Biosyntech's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Biosyntech, which may create opportunities for some arbitrage if properly timed.
Using Biosyntech hype-based prediction, you can estimate the value of Biosyntech from the perspective of Biosyntech response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Biosyntech on the next trading day is expected to be 0.000003 with a mean absolute deviation of 0.000095 and the sum of the absolute errors of 0.01.

Biosyntech after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

Biosyntech Additional Predictive Modules

Most predictive techniques to examine Biosyntech price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biosyntech using various technical indicators. When you analyze Biosyntech charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Biosyntech is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Biosyntech value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Biosyntech Naive Prediction Price Forecast For the 26th of January

Given 90 days horizon, the Naive Prediction forecasted value of Biosyntech on the next trading day is expected to be 0.000003 with a mean absolute deviation of 0.000095, mean absolute percentage error of 0.00000012, and the sum of the absolute errors of 0.01.
Please note that although there have been many attempts to predict Biosyntech Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biosyntech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Biosyntech Pink Sheet Forecast Pattern

Backtest BiosyntechBiosyntech Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Biosyntech pink sheet data series using in forecasting. Note that when a statistical model is used to represent Biosyntech pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria102.2083
BiasArithmetic mean of the errors None
MADMean absolute deviation1.0E-4
MAPEMean absolute percentage error9.223372036854776E14
SAESum of the absolute errors0.0058
This model is not at all useful as a medium-long range forecasting tool of Biosyntech. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Biosyntech. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Biosyntech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biosyntech. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biosyntech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Bollinger
Band Projection (param)
LowMiddleHigh
-0.00090.0000830
Details

Biosyntech Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Biosyntech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biosyntech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biosyntech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.00
0.00
0.00 
0.00  
Notes

Biosyntech Hype Timeline

Biosyntech is currently traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Biosyntech is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Biosyntech is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.1. Biosyntech had not issued any dividends in recent years. The entity had 19:4 split on the 10th of January 2000. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

Biosyntech Related Hype Analysis

Having access to credible news sources related to Biosyntech's direct competition is more important than ever and may enhance your ability to predict Biosyntech's future price movements. Getting to know how Biosyntech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biosyntech may potentially react to the hype associated with one of its peers.

Biosyntech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biosyntech pink sheet to make a market-neutral strategy. Peer analysis of Biosyntech could also be used in its relative valuation, which is a method of valuing Biosyntech by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Story Coverage note for Biosyntech

The number of cover stories for Biosyntech depends on current market conditions and Biosyntech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biosyntech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biosyntech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Biosyntech Pink Sheet

If you are still planning to invest in Biosyntech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biosyntech's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals